Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: The Ideal Diabetes Therapy: What Will It Look Like?How Close Are We?

dosing is not an issue with Afrezza. I think people had established that long time ago. All that is left is the financing problem. This round of financing is still not sufficient for launch.

Share
New Message
Please login to post a reply